Balmoral, Australia

Philip Morrison Giffard

This inventor holds 3 USPTO granted patents. Top assignees: Molecular Staging Inc., Qiagen Gmbh, Other. Active years: 1999-2008.


% Patents Active = 66.7

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 131(Granted Patents)


Company Filing History:


Years Active: 1999-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Philip Morrison Giffard

Introduction

Philip Morrison Giffard is an accomplished inventor based in Balmoral, Australia. He has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid probes. With a total of 3 patents to his name, Giffard's work has implications for genetic research and diagnostics.

Latest Patents

Giffard's latest patents include innovative methods for forming circular nucleic acid probes. One of his notable inventions is a method of amplifying closed circular nucleic acid probes through rolling circle amplification. This method is particularly useful for detecting nucleic acid sequences, which can aid in identifying genetic disorders, genetic variants, and the presence of microbiological or viral agents.

Career Highlights

Throughout his career, Giffard has worked with prominent companies in the biotechnology sector, including Qiagen GmbH and Molecular Staging Inc. His expertise in molecular techniques has positioned him as a valuable contributor to advancements in genetic research.

Collaborations

Giffard has collaborated with notable professionals in his field, including Gregory John Hafner and Lindsay Colin Wolter. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Philip Morrison Giffard's contributions to the field of molecular biology through his innovative patents demonstrate his commitment to advancing genetic research. His work continues to influence the detection and understanding of genetic disorders and microbial agents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…